Cargando…

Clinical characterization and therapeutic targets of vitamin A in patients with hepatocholangiocarcinoma and coronavirus disease

Recent reports indicate that patients with hepatocholangiocarcinoma (CHOL) have a higher morbidity and mortality rate for coronavirus disease (COVID-19). Anti-CHOL/COVID-19 medicines are inexistent. Vitamin A (VA) refers to a potent nutrient with anti-cytotoxic and anti-inflammatory actions. Therefo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Xiao, Zhou, Rui, Li, Yu, Yang, Lu, Su, Min, Lai, Keng Po
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266307/ https://www.ncbi.nlm.nih.gov/pubmed/34176789 http://dx.doi.org/10.18632/aging.203220

Ejemplares similares

Importance of surgical margin in the outcomes of hepatocholangiocarcinoma
por: Ma, Ka Wing, et al.
Publicado: (2017)

Retinal and vitreous metastases from hepatocholangiocarcinoma
por: Praidou, Anna, et al.
Publicado: (2017)

A rare and distinct hepatic tumor: Hepatocholangiocarcinoma
por: Limaiem, Faten, et al.
Publicado: (2021)

Combined Hepatocholangiocarcinoma Associated with Humoral Hypercalcemia of Malignancy and Chronic Inflammatory Demyelinating Polyneuropathy
por: Colunga Biancatelli, Ruben Manuel Luciano, et al.
Publicado: (2019)

Esophageal metastasis of stem cell-subtype hepatocholangiocarcinoma: Rare presentation of a rare tumor
por: Salimon, Maëva, et al.
Publicado: (2018)

Prolonged efficacy of pembrolizumab in a patient presenting a multi-treated metastatic hepatocholangiocarcinoma
por: Saint, Angélique, et al.
Publicado: (2020)

Revealing the targets and mechanisms of vitamin A in the treatment of COVID-19
por: Li, Rong, et al.
Publicado: (2020)

Systemic Treatments with Tyrosine Kinase Inhibitor and Platinum-Based Chemotherapy in Patients with Unresectable or Metastatic Hepatocholangiocarcinoma
por: Gigante, Elia, et al.
Publicado: (2022)

Gemcitabine plus platinum-based chemotherapy for first-line treatment of hepatocholangiocarcinoma: an AGEO French multicentre retrospective study
por: Salimon, Maëva, et al.
Publicado: (2018)

Bioinformatics and in-silico findings reveal medical features and pharmacological targets of biochanin A against colorectal cancer and COVID-19
por: Qin, Jingru, et al.
Publicado: (2021)

Therapeutic targets and functions of curcumol against COVID-19 and colon adenocarcinoma
por: Li, Jun, et al.
Publicado: (2022)

Integrative omics analysis reveals the protective role of vitamin C on perfluorooctanoic acid-induced hepatoxicity
por: Li, Rong, et al.
Publicado: (2021)

Chemotherapeutic Effectiveness of Combining Cetuximab for Metastatic Colorectal Cancer Treatment: A System Review and Meta-Analysis
por: Li, Rong, et al.
Publicado: (2020)

Integrated Analysis Reveals the Targets and Mechanisms in Immunosuppressive Effect of Mesalazine on Ulcerative Colitis
por: Li, Rong, et al.
Publicado: (2022)

Clinical Efficacy and Safety of Eculizumab for Treating Myasthenia Gravis
por: Xiao, Hai, et al.
Publicado: (2021)

Genetic and antigenic characterization of recombinant nucleocapsid proteins derived from canine coronavirus and canine respiratory coronavirus in China
por: Lu, Shuai, et al.
Publicado: (2016)

Preclinical insights into fucoidan as a nutraceutical compound against perfluorooctanoic acid-associated obesity via targeting endoplasmic reticulum stress
por: Liu, Jiaqi, et al.
Publicado: (2022)

Nano‐therapeutic strategies to target coronavirus
por: Rauf, Mohd Ahmar, et al.
Publicado: (2021)

Vitamin D Supplementation: A Potential Approach for Coronavirus/COVID-19 Therapeutics?
por: Arboleda, John F., et al.
Publicado: (2020)

CDH1 is Identified as A Therapeutic Target for Skin Regeneration after Mechanical Loading
por: Huang, Xiaolu, et al.
Publicado: (2021)

Vitamin D and Coronavirus
por: Simonson, William
Publicado: (2020)

Vitamin C and coronavirus
por: Simonson, William
Publicado: (2020)

Revealing the therapeutic targets and molecular mechanisms of emodin-treated coronavirus disease 2019 via a systematic study of network pharmacology
por: Du, Hai-Xia, et al.
Publicado: (2021)

Role of Deubiquitinases in Human Cancers: Potential Targeted Therapy
por: Lai, Keng Po, et al.
Publicado: (2020)

Preclinical characterization of therapeutic antibodies targeted at the carboxy-terminus of Sonic hedgehog
por: Tolani, Bhairavi, et al.
Publicado: (2018)

Pathomechanism characterization and potential therapeutics identification for SCA3 targeting neuroinflammation
por: Chiu, Ya-Jen, et al.
Publicado: (2020)

‘Scientific Strabismus’ or two related pandemics: coronavirus disease and vitamin D deficiency
por: Kara, Murat, et al.
Publicado: (2020)

Anti–coronavirus disease 2019 (COVID‐19) targets and mechanisms of puerarin
por: Qin, Xingyue, et al.
Publicado: (2020)

A Review of Treatment of Coronavirus Disease 2019 (COVID-19): Therapeutic Repurposing and Unmet Clinical Needs
por: Chen, Po-Lin, et al.
Publicado: (2020)

Integrated network findings reveal ubiquitin-specific protease 44 overexpression suppresses tumorigenicity of liver cancer
por: Zhou, Huanhuan, et al.
Publicado: (2023)

Characterization of FGFR signaling pathway as therapeutic targets for sarcoma patients
por: Zhou, Wen-Ya, et al.
Publicado: (2016)

Therapeutics targeting CD90-integrin-AMPK-CD133 signal axis in liver cancer
por: Chen, Wei-Ching, et al.
Publicado: (2015)

Potential therapeutic targets for sarcopenia identified by Mendelian randomisation
por: Jiang, Wei, et al.
Publicado: (2023)

Clinical manifestations of human coronavirus NL63 infection in children in Taiwan
por: Wu, Ping-Sheng, et al.
Publicado: (2007)

Potential Therapeutic Targeting of Coronavirus Spike Glycoprotein Priming
por: Barile, Elisa, et al.
Publicado: (2020)

Coronavirus RNA Proofreading: Molecular Basis and Therapeutic Targeting
por: Robson, Fran, et al.
Publicado: (2020)

Coronavirus RNA Proofreading: Molecular Basis and Therapeutic Targeting
por: Robson, Fran, et al.
Publicado: (2020)

HOTAIR is a therapeutic target in glioblastoma
por: Zhou, Xuan, et al.
Publicado: (2015)

MET Mutation Is a Potential Therapeutic Target for Advanced Endometrial Cancer
por: Yeh, Yu-Min, et al.
Publicado: (2021)

PSMD4 is a novel therapeutic target in chemoresistant colorectal cancer activated by cytoplasmic localization of Nrf2
por: Cheng, Ya-Min, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3vk4909sl64ahajrrmau89mljj